A detailed history of M&T Bank Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, M&T Bank Corp holds 901,347 shares of BMY stock, worth $50.7 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
901,347
Previous 943,470 4.46%
Holding current value
$50.7 Million
Previous $39.2 Million 19.04%
% of portfolio
0.03%
Previous 0.13%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$39.66 - $51.75 $1.67 Million - $2.18 Million
-42,123 Reduced 4.46%
901,347 $46.6 Million
Q2 2024

Jul 31, 2024

SELL
$40.25 - $52.99 $2.72 Million - $3.58 Million
-67,636 Reduced 6.69%
943,470 $39.2 Million
Q1 2024

May 07, 2024

SELL
$47.98 - $54.4 $2.52 Million - $2.86 Million
-52,543 Reduced 4.94%
1,011,106 $54.8 Million
Q4 2023

Feb 06, 2024

SELL
$48.48 - $57.85 $16.7 Million - $19.9 Million
-344,568 Reduced 24.47%
1,063,649 $54.6 Million
Q3 2023

Nov 02, 2023

SELL
$57.89 - $64.73 $3.02 Million - $3.38 Million
-52,147 Reduced 3.57%
1,408,217 $81.7 Million
Q2 2023

Aug 09, 2023

SELL
$63.71 - $70.74 $1.3 Million - $1.44 Million
-20,336 Reduced 1.37%
1,460,364 $93.4 Million
Q1 2023

May 11, 2023

SELL
$65.71 - $74.53 $1.04 Million - $1.18 Million
-15,832 Reduced 1.06%
1,480,700 $103 Million
Q4 2022

Feb 13, 2023

BUY
$68.48 - $81.09 $1.95 Million - $2.31 Million
28,430 Added 1.93%
1,503,531 $108 Million
Q4 2022

Feb 13, 2023

SELL
$68.48 - $81.09 $479,291 - $567,548
-6,999 Reduced 0.47%
1,496,532 $108 Million
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $6,878 - $4.07 Million
52,913 Added 3.72%
1,475,101 $104 Million
Q2 2022

Aug 05, 2022

BUY
$72.62 - $79.98 $4 Million - $4.41 Million
55,101 Added 4.03%
1,422,188 $105 Million
Q1 2022

May 09, 2022

BUY
$61.48 - $73.72 $1.9 Million - $2.28 Million
30,881 Added 2.31%
1,367,087 $99.8 Million
Q4 2021

Feb 07, 2022

SELL
$53.63 - $62.52 $1.78 Million - $2.08 Million
-33,249 Reduced 2.43%
1,336,206 $83.3 Million
Q3 2021

Oct 28, 2021

SELL
$59.17 - $69.31 $4.28 Million - $5.01 Million
-72,256 Reduced 5.01%
1,369,455 $81 Million
Q2 2021

Aug 13, 2021

SELL
$61.91 - $67.42 $3.93 Million - $4.28 Million
-63,453 Reduced 4.22%
1,441,711 $96.3 Million
Q1 2021

May 06, 2021

SELL
$59.34 - $66.74 $5.1 Million - $5.74 Million
-85,992 Reduced 5.4%
1,505,164 $95 Million
Q4 2020

Feb 12, 2021

SELL
$57.74 - $65.43 $1.32 Million - $1.49 Million
-22,798 Reduced 1.41%
1,591,156 $98.7 Million
Q3 2020

Nov 06, 2020

SELL
$57.43 - $63.64 $828,485 - $918,070
-14,426 Reduced 0.89%
1,613,954 $96.3 Million
Q2 2020

Jul 29, 2020

SELL
$54.82 - $64.09 $1.15 Million - $1.34 Million
-20,927 Reduced 1.27%
1,628,380 $94.8 Million
Q1 2020

May 14, 2020

SELL
$46.4 - $67.43 $6.06 Million - $8.81 Million
-130,645 Reduced 7.34%
1,649,307 $91 Million
Q4 2019

Feb 07, 2020

BUY
$49.21 - $64.19 $9.33 Million - $12.2 Million
189,654 Added 11.93%
1,779,952 $108 Million
Q3 2019

Nov 12, 2019

SELL
$42.77 - $50.71 $255,422 - $302,840
-5,972 Reduced 0.37%
1,590,298 $80.6 Million
Q2 2019

Aug 12, 2019

BUY
$44.62 - $49.34 $17.7 Million - $19.6 Million
396,703 Added 33.07%
1,596,270 $72.4 Million
Q1 2019

May 15, 2019

SELL
$45.12 - $53.8 $1.44 Million - $1.72 Million
-31,901 Reduced 2.59%
1,199,567 $57.2 Million
Q4 2018

Feb 01, 2019

SELL
$48.76 - $63.23 $3.08 Million - $4 Million
-63,190 Reduced 4.88%
1,231,468 $64 Million
Q3 2018

Nov 09, 2018

BUY
$55.19 - $62.25 $368,117 - $415,207
6,670 Added 0.52%
1,294,658 $80.4 Million
Q2 2018

Aug 10, 2018

SELL
$50.53 - $62.98 $19.2 Million - $24 Million
-380,505 Reduced 22.81%
1,287,988 $71.3 Million
Q1 2018

May 04, 2018

SELL
$59.92 - $68.98 $281,923 - $324,550
-4,705 Reduced 0.28%
1,668,493 $106 Million
Q4 2017

Feb 06, 2018

SELL
$59.94 - $65.35 $642,376 - $700,355
-10,717 Reduced 0.64%
1,673,198 $103 Million
Q3 2017

Nov 13, 2017

BUY
$55.23 - $63.74 $194,464 - $224,428
3,521 Added 0.21%
1,683,915 $107 Million
Q2 2017

Aug 11, 2017

BUY
N/A
1,680,394
1,680,394 $93.6 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track M&T Bank Corp Portfolio

Follow M&T Bank Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.